Information from Some of the Leading Companies About FDA Regulations.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c37067 ) has announced the addition of Winning Legal Strategies for Food & Drug Companies: A Detailed Look at Regulations, Compliance, and Other Major Legal Issues to their offering. Winning Legal Strategies for Food and Drug Companies is an authoritative, insiders perspective on the legal issues companies face in meeting FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. regulations. Featuring department heads, group chairs, and leading partners representing some of the nations top firms, this book provides a broad, yet comprehensive overview of this highly-regulated practice area. From gaining FDA approval for a product to complying with FDA policies once the product is introduced on the market, these seasoned professionals cover the important aspects of the practice area. The different niches and breadth of perspectives represented these outstanding authors enable readers to get inside some of the great legal minds of today, as experts offer up their thoughts around the keys to success. For understanding and implementing the practices that separate insiders from the rest, Winning Legal Strategies for Food and Drug Companies is truly an indispensable resource. Chapters include: 1) James N. Czaban , Shareholder and Chair, FDA Practice Group, Heller Ehrman Heller Ehrman LLP is an international law firm of more than 700 attorneys working across 13 offices in the United States, Europe, and Asia.[2] Heller Ehrman was founded in San Francisco in 1890 and has additional offices located in most of the major financial centers LLP LLP - Lower Layer Protocol : "Being Compliant While Standing Your Ground"; 2) Carolyne Hathaway, Partner, and John Manthei, Partner: Latham & Watkins- "Stepping in Early and Adding Real Value"; 3) Sandra sandra (sänˑ·dr  ),adj D. Morar, Member, McGrath, North, Mullin & Kratz, "An Overview of What a Food Lawyer Needs to Know"; 4) William C. Waller, Corporate Regulatory Counsel, Chiron Corporation Chiron Corporation was a multinational biotechnology firm based in Emeryville, California that was acquired by Novartis International AG on April 20 2006. It had offices and facilities in eighteen countries on five continents. , "Drug Law: An In-House In-house In the context of general equities, keeping an activity within the firm. For example, rather than go to the marketplace and sell a security for a client to anyone, an attempt is made to find a buyer to complete the transaction with the firm. Lawyer's Perspective"; 5) John A. Gilbert Jr., Director, Hyman, Phelps & McNamara PC: "The Regulation of Controlled Substances controlled substance n. a drug which has been declared by federal or state law to be illegal for sale or use, but may be dispensed under a physician's prescription. "; 6) Marsha C. Wertzberger, Member, & Wayne .H. Matelski, Member: Arent Fox - "Increasing the Company's Understanding of How It Is Regulated"; 7) Robert B. Nicholas, Partner and Chair, FDA Practice Group, McDermott Will & Emery emery: see corundum. emery Granular rock consisting of a mixture of the mineral corundum (aluminum oxide, Al2O3) and iron oxides such as magnetite (Fe3O4) or hematite (Fe2O3). LLP: "Science, Law, and Politics for FDA-Regulated Companies"; 8) Charles R. McConachie, Partner, Simpson Woolley McConachie: "Keys to Success: Being Honest, Educated, and Timely"; 9) Frederick A. Stearns, Partner, Keller and Heckman LLP, "Getting Things Right from the Beginning." For more information visit http://www.researchandmarkets.com/reports/c37067 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion